Skip to main content

Clinical Trials in the Time of COVID-19


Date: April 21, 2020

Time: 1:00PM - 2:00PM (EST)

Location: View the Webinar Recording

Join Mintz for the next installment in our COVID-19 webinar series for life sciences companies. This session will explore the widespread disruptions the crisis is posing to clinical trials for life sciences companies and to research study sites. We will also discuss recent guidance from regulatory authorities and practical steps for both sponsors and researchers to address emerging issues. 

The program will cover the following topics:
•    Regulatory authority accommodations for ongoing clinical trials that may be affected by COVID-19 and  regional restrictions
•    Overview of the current clinical trials landscape during the COVID-19 pandemic
•    Key considerations for sponsors and study sites regarding ongoing and planned clinical trials
•    Considerations for companies interested in commencing a clinical trial for a COVID-19 product candidate


Dianne specializes in counseling researchers and research sponsors in matters related to FDA and OHRP regulated clinical research, and counsels health care clients on the HIPAA Privacy Rule and Security Standards.
Benjamin advises pharmaceutical, medical device and biotech companies on the FDA regulatory process to identify the correct regulatory pathway, assisting with FDA communications and strategy.

More Events